Page results
-
The National Hospital for Neurology and Neurosurgery (NHNN) has one of the largest, most comprehensive programmes in Europe for the evaluation and medical and surgical treatment of epilepsy.
-
The Headache Service provides advice and treatment to patients referred for the management of all headache disorders.
-
Our team deliver care to people with MS and aim to provide specialist services, share information on how to manage symptoms, offer education sessions, medication options and rehabilitation services.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and neuro-oncology service to patients.
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
The Headache and Facial Pain Group is internationally recognised as a centre of clinical and academic excellence in the management of complex head and facial pain disorders.
File results
-
FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia
-
FOI/2023/0832 - Hospital admissions for vaping related disorders
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers
-
FOI/2023/0849 - Physician Associates
-
FOI/2023/0870 - Cancer treatments cancelled or rescheduled